These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22226043)

  • 1. Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice.
    Marshall AM; McClaine RJ; Gurusamy D; Gray JK; Lewnard KE; Khan SA; Waltz SE
    Mol Cancer; 2012 Jan; 11():2. PubMed ID: 22226043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation.
    Zinser GM; Leonis MA; Toney K; Pathrose P; Thobe M; Kader SA; Peace BE; Beauman SR; Collins MH; Waltz SE
    Cancer Res; 2006 Dec; 66(24):11967-74. PubMed ID: 17178895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
    Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
    Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
    Johnson AL; Zinser GM; Waltz SE
    Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines.
    McClaine RJ; Marshall AM; Wagh PK; Waltz SE
    Neoplasia; 2010 Aug; 12(8):650-8. PubMed ID: 20689759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice.
    Meyer SE; Peace BE; Bahassi el M; Kavanaugh GM; Wagh PK; Robbins SB; Yin M; Wells SI; Zinser GM; Stambrook PJ; Waltz SE
    Cancer Lett; 2010 Oct; 296(2):186-93. PubMed ID: 20434834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer.
    Peace BE; Toney-Earley K; Collins MH; Waltz SE
    Cancer Res; 2005 Feb; 65(4):1285-93. PubMed ID: 15735014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.
    Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
    Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Catenin is required for Ron receptor-induced mammary tumorigenesis.
    Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE
    Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
    Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
    Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
    Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
    Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
    Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
    Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
    Wagh PK; Peace BE; Waltz SE
    Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
    Cornelissen LM; Henneman L; Drenth AP; Schut E; de Bruijn R; Klarenbeek S; Zwart W; Jonkers J
    J Mammary Gland Biol Neoplasia; 2019 Dec; 24(4):305-321. PubMed ID: 31729597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
    Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
    Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.
    Bourn JR; Ruiz-Torres SJ; Hunt BG; Benight NM; Waltz SE
    Cancer Lett; 2021 Apr; 503():75-90. PubMed ID: 33508385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
    Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
    Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.